Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour
- 31 March 1988
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (4) , 385-389
- https://doi.org/10.1038/bjc.1988.87
Abstract
A comparison has been made of the cachectic effects produced by the transplantable murine adenocarcinoma of the mouse colon (MAC16) with tumour necrosis factor-.alpha. (cachectin). Tumour necrosis factor-.alpha. (TNF-.alpha.) produced a dose-related weight reduction that was accompanied by a decrease in both food and water intake. The degree of weight loss was directly proportional to the decreased food and water intake. In contrast weight loss produced by the MAC16 tumour occurred without a reduction in fluid or nutrient intake. Both the MAC16 tumour and TNF-.alpha. produced hypoglycaemia and a reduction in the circulatory level of free fatty acids (FFA), but had opposite effects on the level of plasma triglycerides with the MAC16 tumour-induced cachexia causing a decrease and TNF-.alpha. producing an increase. The MAC16 tumour elaborated a lipolytic factor which caused an immediate release of FFA from adipose tissue. In contrast, TNF-.alpha. had no effect on mobilization of adipose triglycerides over a short time period. Both TNF-.alpha. and extracts from the MAC16 tumour caused an enhanced release of amino acids from mouse diaphragm, which was suppressible with indomethacin and heat labile. No TNF was detected in the MAC16 tumour or in the serum of tumour-bearing animals. Both tumour and non-tumour-bearing animals responded with a similar elevation of their serum TNF levels 90 min after a single injection of endotoxin. It is concluded that weight loss produced by TNF-.alpha. arises from an anorexic effect and that this differs from the complex metabolic changes associated with cancer cachexia.Keywords
This publication has 17 references indexed in Scilit:
- The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.Proceedings of the National Academy of Sciences, 1987
- Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor—The primary regulatory role of the hormone in 3T3-L1 adipocytesArchives of Biochemistry and Biophysics, 1986
- Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Production of tumor necrosis factor in unprimed mice: Mechanism of endotoxin-mediated tumor necrosisImmunobiology, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: The role of cachectin (tumor necrosis factor)Immunology Letters, 1985
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factorEuropean Journal of Biochemistry, 1985
- A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of CachexiaScience, 1985
- Comparison of in vitro cell cytotoxic assays for tumor necrosis factorJournal of Immunological Methods, 1984